FDA Seeks to Increase Regulatory Oversight of Laboratory Developed Tests

On October 3, the US Food and Drug Administration (FDA) issued a proposed rule regarding the regulation of in vitro diagnostic products (IVDs). In this proposed rule, the FDA announced its intent to amend its regulations to provide that laboratory developed tests (LDTs) are medical devices under the federal Food, Drug, and Cosmetic Act (FDCA) and are subject to all accompanying regulations….
By: ArentFox Schiff
Previous Story

Dollar Energy Fund Notifies More than 28k Individuals of Recent Data Breach That Leaked Their SSNs

Next Story

Telehealth Update: DEA Extends Flexibility in Prescribing Controlled Substances via Telehealth Through 2024